Vibrio cholerae is the causative agent of cholera, an acute life-threatening diarrhoeal disease endemic in many developing countries and responsible for seven pandemics. There are more than 200 known serogroups of Vibrio cholerae, however only two, O1 and O139 cause cholera. V. cholerae O139 strains were identified as the causative agent for a cholera epidemic that broke out in parts of Bangladesh and India between 1992 and 1993. These serotypes are further differentiated into two biotypes (Classical and El Tor) based on genotypic and phenotypic differences. Since 1817 all of the early pandemics were exclusively attributable to strains of the classical biotype. However, by the 1960’s El Tor replaced the classical biotype as the major cause of cholera. The re-emergence of classical strains in Bangladesh in 1982 resulted in a temporal overlap during which both biotypes co-existed for around a decade, however the classical biotype now seems to be extinct. New hybrid variants of V. cholerae O1 that display representative traits of both biotypes have recently been isolated. Thus, genotypic traits that have traditionally been viewed as distinguishing features of a particular biotype are now of limited value. Our current work is aimed at understanding the sequence diversity held within this species.
Jan Holmgren (Gothenburg University)
Dong Wook Kim (International Vaccine Institute)
Ranjan K. Nandy (National Institute of Cholera and Enteric Diseases)
Sam Kariuki (Centre for Microbiology Research, Kenya)
- Discovery of sequence diversity in Vibrio sp.
- Investigating the diversity of Vibrio cholerae isolates
- Salmonella enterica ser. Typhimurium in Argentina
- Vibrio cholerae sequencing
- Understanding the historical spread of cholera from West Africa to South America in the 1990¬ís
- PacBio sequencing of Vibrio cholerae samples
- Tucuman Variant of Vibrio cholerae
Evidence for several waves of global transmission in the seventh cholera pandemic.
This project is ongoing and data for this organism will be made available in due course.
Data Use Statement
This sequencing centre plans on publishing the completed and annotated sequences in a peer-reviewed journal as soon as possible. Permission of the principal investigator should be obtained before publishing analyses of the sequence/open reading frames/genes on a chromosome or genome scale. See our data sharing policy.
Please address all sequencing enquiries to: email@example.com